封面
市场调查报告书
商品编码
1863891

预填充式注射器市场:按材料、药物类型、设计、产品类型、性别、製造方法、最终用户和地区划分

Prefilled Syringes Market, By Material, By Drug Type, By Design, By Product Type, By Usability, By Manufacturing Method, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 401 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年,预填充式注射器市场价值将达到 71.8 亿美元,预计到 2032 年将达到 105.1 亿美元,2025 年至 2032 年的复合年增长率为 5.6%。

报告范围 报告详情
基准年: 2024 2025年市场规模: 71.8亿美元
性能数据: 2020年至2024年 预测期: 2025年至2032年
预测期(2025-2032年)复合年增长率: 5.60% 2032年价值预测 105.1亿美元

预填充式注射器是预先装有待注射药物的一次性注射器。它们是单剂量注射器,针头由製造商预先安装。由于这些注射器已预先填充药物,护士和患者无需准备药物并将其吸入针头;正确的剂量已在註射器内,可实现快速注射。此外,预填充式注射器因其高精度而使用起来更安全。一些预填充式注射器药筒设计用于自吸式註射器,透过穿透皮肤输送药物,无需按压活塞。这确保了药物的顺畅输送,并确保注射达到适当的深度。

市场动态

慢性病发病率的不断上升预计将推动预填充式注射器作为治疗选择的需求,从而在预测期内促进市场成长。例如,根据美国疾病管制与预防中心 (CDC) 于 2022 年 7 月更新的慢性病数据,美国约有 60% 的成年人患有某种慢性病,超过 40% 的成年人患有两种或两种以上的慢性病。癌症是全球影响人数最多的慢性病。例如,根据 GLOBOCAN 2020 报告,2020 年全球癌症病例总数约为 19,292,789 例。预计到2040年,这一数字将增加至28,887,940例。多种癌症正在使用新型药物和生物製药进行治疗,预计将增加2025年至2032年预测期内对预填充式注射器的需求。因此,全球癌症病例的增加预计将在预测期内推动预填充式注射器市场的成长。

随着市场参与企业不断拓展产品系列,监管机构核准的药品数量持续增加,预计将推动市场在预测期内成长。例如,2022年12月,跨国製药公司Alembic Pharmaceuticals Limited宣布,其美国剂量预核准式註射器装的氟维司群注射预填充式注射器(250毫克/5毫升,50毫克/毫升)的简略新药申请(ANDA)已获得食品药物管理局(FDA)的最终批准。氟维司群注射液是一种雌激素受体拮抗剂,用于治疗乳癌。

本次调查的主要特点

  • 本报告对全球预填充式注射器市场进行了详细分析,以 2024 年为基准年,对 2025 年至 2032 年的预测期内市场规模和復合年增长率 (%) 进行了预测。
  • 该报告重点介绍了各个细分市场的潜在商机,并为该市场说明了一个具有吸引力的投资提案矩阵。
  • 该报告还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
  • 本报告根据以下参数对全球预填充式注射器市场的主要参与者进行了分析:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告的研究结果将使负责人和企业经营团队能够就即将推出的产品、类型升级、市场扩张和行销策略做出明智的决策。
  • 本报告的目标受众是全球预填充式注射器市场的各个相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过各种用于分析全球预填充式注射器市场的策略矩阵轻鬆做出决策。

目录

第一章:调查目标和前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章:市场动态、监理及趋势分析

  • 市场动态
    • 司机
    • 抑制因素
    • 市场吸引力分析
    • 市场机会
  • 产品发布
  • 合併、收购和合作
  • 监管准则与合规性
  • 重大进展
  • PEST分析
  • 技术格局
  • 服务成本分析

4. 2025-2032年全球预填充式注射器市场(依材料划分)

  • 玻璃
  • 塑胶/聚合物

5. 2025-2032年全球预填充式注射器市场(依药物类型划分)

  • 生物製药
  • 疫苗
  • 胰岛素
  • 抗凝血剂
  • 生理食盐水注射器
  • 其他的

6. 2025-2032年全球预填充式注射器市场(依类型划分)

  • 单人房
  • 双腔型
  • 多腔型

7. 2025-2032年全球预填充式注射器市场(依产品类型划分)

  • 预填充式注射器,附针头
  • 无针预填充式注射器

8. 全球预填充式注射器市场(依使用者性别划分),2025-2032 年

  • 一次性的
  • 可重复使用的

9. 2025-2032年全球预填充式注射器市场依生产方法划分

  • 内部生产类型
  • 商业销售类型

10. 2025-2032年全球预填充式注射器市场(依最终使用者划分)

  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

第十一章:2025-2032年全球预填充式注射器市场(按地区划分)

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韩国
      • 亚太其他地区
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中非
      • 南非

第十二章 竞争格局

  • Gerresheimer AG
  • Becton, Dickinson and Company
  • West Pharmaceutical Services, Inc.
  • Terumo Corporation
  • Nipro Europe Group Companies
  • B.Braun SE
  • GSK plc.
  • Pfizer Inc.
  • Bayer AG
  • Polymedicure
  • Amsino International, Inc.
  • Leeford Healthcare Limited
  • Torrent Pharmaceuticals Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Ypsomed AG
  • SOL-Millennium
  • Stevanato Group SpA

第十三章各节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI162

Prefilled Syringes Market is estimated to be valued at USD 7.18 Bn in 2025 and is expected to reach USD 10.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 7.18 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.60% 2032 Value Projection: USD 10.51 Bn

Pre-filled syringes are single-use syringes that are pre-loaded with the medication that will be injected. It is a single dose of medicine with a needle attached by the manufacturer. As these syringes are prefilled, nurses or patients do not need to prepare the medication and pull it into the needle; instead, the appropriate dosage is already present in the barrel and is ready for speedy injection. Moreover, prefilled syringes are safer to use since they are highly accurate. Some cartridges of prefilled syringes are made to fit into self-aspirating syringes, which penetrate the skin and provide drugs without the need to press a plunger. This guarantees that doses are supplied smoothly and that injections reach the proper depth.

Market Dynamics

Increasing incidence of chronic diseases which leads to driving the demand of prefilled syringes as its treatment is expected to fuel the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention data on chronic diseases updated in July 2022, around six in ten adults in the U.S. were affected by a type of chronic disease, and over four in ten adults were affected by two or more chronic diseases. Cancer is the most common chronic disease affecting people worldwide. For instance, according to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounted for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. Several types of cancer are treated with the help of novel drugs and biologics, which is expected to increase the demand for prefilled syringes over forecast period 2025-2032. Thus, the rising cancer cases across the world is expected to boost the growth of the prefilled syringes market over the forecast period.

The increasing approvals from various regulatory agencies by market players to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2022, Alembic Pharmaceuticals Limited, a multinational pharmaceutical company, announced that it had received final approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.

Key features of the study

  • This report provides in-depth analysis of the global prefilled syringes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global prefilled syringes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prefilled syringes market

Market Segmentation

  • Global Prefilled Syringes Market, By Material
    • Glass
    • Plastic/Polymer
  • Global Prefilled Syringes Market, By Drug Type
    • Biologics
    • Monoclonal Antibodies
    • Blood Products
    • Others (Erythropoietin, Therapeutic proteins, among others)
    • Vaccines
    • Conjugated Vaccines
    • Live Attenuated Vaccines
    • Recombinant Vaccines
    • Others (Virus-like particles (VLPs), Viral vector vaccines)
    • Insulin
    • Anticoagulants
    • Flush Saline Syringes
    • Others
  • Global Prefilled Syringes Market, By Design
    • Single-chamber
    • Dual-chamber
    • Multi-chambered
  • Global Prefilled Syringes Market, By Product Type
    • Staked in-needle pre-filled syringes
    • Needle-free pre-filled syringes
  • Global Prefilled Syringes Market, By Usability
    • Disposable
    • Reusable
  • Global Prefilled Syringes Market, By Manufacturing Method
    • Captive
    • Merchant
  • Global Prefilled Syringes Market, By End User
    • Hospital
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Prefilled Syringes Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Gerresheimer AG
    • Becton, Dickinson and Company
    • West Pharmaceutical Services, Inc.
    • Terumo Corporation
    • Nipro Europe Group Companies
    • B. Braun SE
    • Sanofi
    • GSK plc.
    • Pfizer Inc.
    • Bayer AG
    • Polymedicure
    • Amsino International, Inc.
    • Leeford Healthcare Limited
    • Torrent Pharmaceuticals Ltd.
    • Regeneron Pharmaceuticals Inc.
    • Ypsomed AG
    • SOL-Millennium
    • Stevanato Group S.p.A.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Material
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Design
    • Market Snapshot, By Product Type
    • Market Snapshot, By Usability
    • Market Snapshot, By Manufacturing Method
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • Service Cost Analysis

4. Global Prefilled Syringes Market, By Material, 2025-2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Glass
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Plastic/Polymer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

5. Global Prefilled Syringes Market, By Drug Type, 2025-2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
      • Monoclonal Antibodies
      • Blood Products
      • Others (Erythropoietin, Therapeutic proteins, among others)
  • Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
      • Conjugated Vaccines
      • Live Attenuated Vaccines
      • Recombinant Vaccines
      • Others (Virus-like particles (VLPs), Viral vector vaccines)
  • Insulin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Anticoagulants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Flush Saline Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

6. Global Prefilled Syringes Market, By Design, 2025 - 2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Single-chamber
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Dual-chamber
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Multi-chambered
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

7. Global Prefilled Syringes Market, By Product Type, 2025 - 2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Staked in-needle pre-filled syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Needle-free pre-filled syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

8. Global Prefilled Syringes Market, By Usability, 2025 - 2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Disposable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Reusable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

9. Global Prefilled Syringes Market, By Manufacturing Method, 2025 - 2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Captive
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Merchant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

10. Global Prefilled Syringes Market, By End User, 2025 - 2032, (US$ Billion

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segments Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

11. Global Prefilled Syringes Market, By Region, 2025 - 2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2025 - 2032, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa

12. Competitive Landscape

  • Gerresheimer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • West Pharmaceutical Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nipro Europe Group Companies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • B.Braun SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Polymedicure
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amsino International, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Leeford Healthcare Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Torrent Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Regeneron Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ypsomed AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SOL-Millennium
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stevanato Group S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

13. Section

  • Research Methodology
  • About Us